Figure 3.
Potential saved costs from avoided skin cancers 2014‐2045 in million € Cost‐savings based on the number of potential avoided cases and the discontinued average case‐costs
Potential saved costs from avoided skin cancers 2014‐2045 in million € Cost‐savings based on the number of potential avoided cases and the discontinued average case‐costs